(Q28611484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b (English)

2 references

3 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

0 references

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

11

H Tumani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

J Brettschneider

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

D Ecker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

A Bitsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

D Bahner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

T Bogumil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

E Elitok

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

B Kitze

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

S Poser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

F Weber

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

2 references

3 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

15 December 2019

published in

2 references

3 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

133

2 references

3 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1-2

2 references

3 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

193-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Apoptosis. Phagocytic docking without shocking

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Interferon-beta induces the development of type 2 dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Immunologic therapy for secondary and primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Monocyte activity in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Increased levels of circulating soluble CD14 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

Measurement of intracellular cytokines in MS patients treated with beta-interferon and association of a beta-interferon induced exacerbation with increased expression of gamma-interferon by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900353-3

7 January 2021

10.1016/S0165-5728(02)00353-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12446022%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

2 references

3 February 2017